Published in Int J Epidemiol on February 01, 2002
JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart (2005) 9.79
Social and physical environments and disparities in risk for cardiovascular disease: the healthy environments partnership conceptual model. Environ Health Perspect (2005) 3.08
Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial. BMJ (2010) 1.89
Associations between body mass index and the prevalence of low micronutrient levels among US adults. MedGenMed (2006) 1.63
Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity. J Epidemiol Community Health (2007) 1.32
Homocysteine lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev (2009) 1.17
Epidemiology and risk factors of cerebral ischemia and ischemic heart diseases: similarities and differences. Curr Cardiol Rev (2010) 1.04
Total plasma homocysteine, folate, and vitamin B12 status in healthy Iranian adults: the Tehran homocysteine survey (2003-2004)/a cross-sectional population based study. BMC Public Health (2006) 1.03
Plasma homocysteine, MTHFR C677T, CBS 844ins68bp, and MTHFD1 G1958A polymorphisms in spontaneous cervical artery dissections. J Neurol (2004) 0.98
Effect of consumption of tomato juice enriched with n-3 polyunsaturated fatty acids on the lipid profile, antioxidant biomarker status, and cardiovascular disease risk in healthy women. Eur J Nutr (2011) 0.89
Pre-operative homocysteine levels and morbidity and mortality following cardiac surgery. Eur Heart J (2009) 0.88
Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels. Vasc Health Risk Manag (2007) 0.87
Commentary: an updated review of the published studies of homocysteine and cardiovascular disease. Int J Epidemiol (2002) 0.84
Is a low blood level of vitamin B12 a cardiovascular and diabetes risk factor? A systematic review of cohort studies. Eur J Nutr (2010) 0.83
Hyperhomocysteinemia and mortality after coronary artery bypass grafting. PLoS One (2006) 0.81
Plasma folate, but not homocysteine, is associated with Apolipoprotein A1 levels in a non-fortified population. Lipids Health Dis (2013) 0.79
Homocysteine levels in chronic gastritis and other conditions: relations to incident cardiovascular disease and dementia. Dig Dis Sci (2009) 0.78
Homocysteine and coronary heart disease: the importance of a distinction between low and high risk subjects. Int J Epidemiol (2002) 0.77
Homocysteine and cognitive function in institutionalised elderly A cross-sectional analysis. Eur J Nutr (2005) 0.77
Is there a causal role for homocysteine concentration in blood pressure? A Mendelian randomization study. Am J Clin Nutr (2015) 0.75
5,10-methylene tetrahydrofolate reductase C677T gene polymorphism, homocysteine concentration and the extent of premature coronary artery disease in southern Iran. EXCLI J (2013) 0.75
The predictive value of vitamin B12 concentrations and hyperhomocysteinaemia for cardiovascular disease. Neth Heart J (2007) 0.75
South African lamb and cardiovascular disease risk. Cardiovasc J Afr (2007) 0.75
Homocysteine and leukoaraiosis: time for a clinical trial? Neurol Sci (2007) 0.75
Age and kidney function are the primary correlates of fasting plasma total homocysteine levels in non-diabetic and diabetic adults. Results from the 1999-2002 National Health and Nutrition Examination Survey. Nutr Metab (Lond) (2005) 0.75
Interactions between lifestyle and MTHFR polymorphisms on homocysteine concentrations in young adults belonging to the 1982 Pelotas Birth Cohort. Eur J Clin Nutr (2016) 0.75
Non-invasive assessment of coronary calcification. Eur J Epidemiol (2004) 0.75
Actual causes of death in the United States, 2000. JAMA (2004) 44.38
Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care (2002) 10.00
Public health surveillance for behavioral risk factors in a changing environment. Recommendations from the Behavioral Risk Factor Surveillance Team. MMWR Recomm Rep (2003) 4.28
Interventions to prevent skin cancer by reducing exposure to ultraviolet radiation: a systematic review. Am J Prev Med (2004) 4.07
Correction: actual causes of death in the United States, 2000. JAMA (2005) 3.30
Diabetes Antibody Standardization Program: first assay proficiency evaluation. Diabetes (2003) 3.09
Worsening trends in adult health-related quality of life and self-rated health-United States, 1993-2001. Public Health Rep (2004) 2.99
The impact of stretching on sports injury risk: a systematic review of the literature. Med Sci Sports Exerc (2004) 2.98
Cardiovascular risk factors and confounders among nondrinking and moderate-drinking U.S. adults. Am J Prev Med (2005) 2.88
Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for national institute of diabetes and digestive and kidney diseases consortia. J Clin Endocrinol Metab (2010) 2.70
Planning an integrated disease surveillance and response system: a matrix of skills and activities. BMC Med (2007) 1.93
Strengthening capacity in developing countries for evidence-based public health: the data for decision-making project. Soc Sci Med (2003) 1.90
Counting hard-to-count populations: the network scale-up method for public health. Sex Transm Infect (2010) 1.89
Systematic environmental evaluations to identify food safety differences between outbreak and nonoutbreak restaurants. J Food Prot (2006) 1.61
Statins and risk of cancer: a retrospective cohort analysis of 45,857 matched pairs from an electronic medical records database of 11 million adult Americans. J Am Coll Cardiol (2011) 1.59
Effects of exposure to low levels of environmental cadmium on renal biomarkers. Environ Health Perspect (2002) 1.54
Public health surveillance and knowing about health in the context of growing sources of health data. Am J Prev Med (2011) 1.52
Perspectives on public health workforce research. J Public Health Manag Pract (2009) 1.41
Investigating childhood leukemia in Churchill County, Nevada. Environ Health Perspect (2007) 1.40
Prevention of lower extremity stress fractures in athletes and soldiers: a systematic review. Epidemiol Rev (2002) 1.32
Measuring the public's health. Public Health Rep (2006) 1.32
Are we there yet? Seizing the moment to integrate medicine and public health. Am J Public Health (2012) 1.31
Childhood obesity: a framework for policy approaches and ethical considerations. Prev Chronic Dis (2011) 1.21
Public goods and externalities: a research agenda for public health economics. J Public Health Manag Pract (2007) 1.20
Revisiting the use of the electronic fetal monitor. Lancet (2003) 1.17
Health burden and funding at the Centers for Disease Control and Prevention. Am J Prev Med (2006) 1.17
Diabetes antibody standardization program: first proficiency evaluation of assays for autoantibodies to zinc transporter 8. Clin Chem (2011) 1.17
Application of proteomics in the discovery of candidate protein biomarkers in a diabetes autoantibody standardization program sample subset. J Proteome Res (2007) 1.16
Epidemiology and education: using public health for teaching mathematics and science. Public Health Rep (2007) 1.16
Combined testing of antibody titer and affinity improves insulin autoantibody measurement: Diabetes Antibody Standardization Program. Clin Immunol (2006) 1.13
The prevention of shin splints in sports: a systematic review of literature. Med Sci Sports Exerc (2002) 1.11
Genetic variants associated with fasting blood lipids in the U.S. population: Third National Health and Nutrition Examination Survey. BMC Med Genet (2010) 1.05
Evaluation of field training in the epidemic intelligence service: publications and job choices. Am J Prev Med (2004) 1.01
Public health surveillance and the prevention of injuries in sports: what gets measured gets done. J Athl Train (2007) 0.99
Epidemic assistance by the Centers for Disease Control and Prevention: role of the Epidemic Intelligence Service, 1946-2005. Am J Epidemiol (2011) 0.99
Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes. J Exp Med (2012) 0.98
In snow's footsteps: Commentary on shoe-leather and applied epidemiology. Am J Epidemiol (2010) 0.98
The cornerstone of public health practice: public health surveillance, 1961--2011. MMWR Surveill Summ (2011) 0.95
The education of physicians: a CDC perspective. Acad Med (2008) 0.95
Are we there yet? Seizing the moment to integrate medicine and public health. Am J Prev Med (2012) 0.94
HFE genotype and transferrin saturation in the United States. Genet Med (2003) 0.91
Nephropathy in type 1 diabetes is diminished in carriers of HLA-DRB1*04: the genetics of kidneys in diabetes (GoKinD) study. Diabetes (2007) 0.90
Laboratory contributions to public health. MMWR Surveill Summ (2011) 0.87
Predicting type 1 diabetes using autoantibodies: the latest results from the diabetes autoantibody standardization program. Diabetes Technol Ther (2002) 0.86
Measuring health program effectiveness in the field: an assessment tool. Prehosp Disaster Med (2007) 0.85
Commentary: what contributes to a successful career in epidemiology in the United States? Am J Epidemiol (2002) 0.85
Electronic fetal monitoring. Lessons from a formative case of health technology assessment. Int J Technol Assess Health Care (2002) 0.84
How do we ensure the quality of the public health workforce? Prev Chronic Dis (2005) 0.84
The ethics of access to online genetic databases: private or public? Am J Pharmacogenomics (2002) 0.83
Assessment of DNA contamination from dried blood spots and determination of DNA yield and function using archival newborn dried blood spots. Clin Chim Acta (2008) 0.82
Sequence variants in the PLEKHH2 region are associated with diabetic nephropathy in the GoKinD study population. Hum Genet (2008) 0.82
Monitoring progress toward CDC's health protection goals: health outcome measures by life stage. Public Health Rep (2009) 0.82
Perturbations in the lipid profile of individuals with newly diagnosed type 1 diabetes mellitus: lipidomics analysis of a Diabetes Antibody Standardization Program sample subset. Clin Biochem (2010) 0.82
Health communication ethics and CDC quality-control guidelines for information. Public Health Rep (2003) 0.81
Polymorphism scan for differences between transmitted and nontransmitted DRB1*030101 alleles outside of exon 2 for type 1 diabetes: the frequency of polymorphisms is similar. Hum Immunol (2004) 0.81
Rationale for periodic reporting on the use of adult clinical preventive services of public health priority--United States. MMWR Morb Mortal Wkly Rep (2012) 0.81
Diabetes Antibody Standardization Program: First evaluation of assays for autoantibodies to IA-2β. Diabetes Care (2011) 0.80
Factors associated with differences in mortality and self-reported health across states in the United States. Health Policy (2009) 0.79
The value of prevention: experiences of a public health agency. Med Decis Making (2002) 0.77
Thrombomodulin Ala455Val Polymorphism and the risk of cerebral infarction in a biracial population: the Stroke Prevention in Young Women Study. BMC Neurol (2004) 0.77
Guide for applied public health workforce research: an evidence-based approach to workforce development. J Public Health Manag Pract (2009) 0.76
Methods and interpretation in systematic reviews: commentary on two parallel reviews of epidural analgesia during labor. Am J Obstet Gynecol (2002) 0.76
Evolution of epidemic investigations and field epidemiology during the MMWR era at CDC--1961-2011. MMWR Surveill Summ (2011) 0.75
Introductory remarks. Public Health Rep (1987) 0.75
Novel human leukocyte antigen class I and class II alleles identified by sequence-based typing in the Genetics of Kidneys in Diabetes (GoKinD) study population. Hum Immunol (2009) 0.75
Public health then and now: celebrating 50 years of MMWR at CDC. Introduction. MMWR Surveill Summ (2011) 0.75
Rationale for periodic reporting on the use of selected clinical preventive services to improve the health of infants, children, and adolescents--United States. MMWR Surveill Summ (2014) 0.75
Veterinarians and public health: the Epidemic Intelligence Service of the Centers for Disease Control and Prevention, 1951-2002. J Vet Med Educ (2003) 0.75
Identification of two novel DQA1 alleles, DQA1*0107 and DQA1*0602, by sequence-based typing in the GoKinD population. Hum Immunol (2006) 0.75
Tools for public health assessment in the twenty-first century. J Public Health Manag Pract (2002) 0.75
Using science-based guidelines to shape public health law. J Law Med Ethics (2003) 0.75
Hormone therapy: making decisions in the face of uncertainty. Arch Intern Med (2004) 0.75
The value of public health services and systems research. Am J Prev Med (2012) 0.75
Methods for conducting systematic reviews of targeted vaccination strategies for the guide to community preventive services. Am J Prev Med (2005) 0.75
U.S. military officer participation in the Centers for Disease Control and Prevention's Epidemic Intelligence Service (1951-2001). Mil Med (2003) 0.75
Surveillance and the Tao of leadership: a perspective from the United States. Soz Praventivmed (2005) 0.75